Apax Dispatch - April 2021 Edition

Apax Rebranded 

As you might have seen, we have been busy rebranding to bring our visual identity closer in line with our values, focus on digital and the firm’s wider activities. Watch this video to learn more or check out our new website

​​​​​​​​​​​​​​“We wanted to make sure our brand more closely reflected our culture and values, encapsulating our vision and ‘intent’.”​​​​​​​
Our Apax Values

Sustainability In Focus

8TH EDITION OF THE APAX SUSTAINABILITY REPORT​​​​​​​

The recent unprecedented times have underscored the importance of an integrated approach to creating strong and robust businesses, supporting the investment case for ESG. The current crisis has proved the value of resilience and long-term sustainable strategies.
​​​​​​​
Read the 8th edition of Apax’s Sustainability Report to learn more about key initiatives across the Apax Funds’ portfolio and how we measure and create value.

​​​​​​​Read the report here

Portfolio Company Update

Just before International Women’s Day, Apax Funds’ portfolio company InnovAge went public with a largely female leadership team. In the words of CEO, Maureen Hewitt, “Diversity is key!”

The value-based senior care provider started trading on the Nasdaq Global Select Market on March 4th 2021, using the ticker symbol ‘INNV’ and closed up 15% at $24.20 per share, implying an enterprise value of $3.2bn.

Following the Apax Funds’ investment in InnovAge, Apax’s healthcare team and Operational Excellence practice worked closely with the management team to help accelerate growth by shifting focus toward digital marketing channels, and increasing investment in technology. As a public company, we expect that InnovAge will further increase awareness of its model and be able to serve more frail seniors in the years to come. 

Learn more about InnovAge here and watch the Nasdaq Opening Bell here ​​​​​​​​​​​​​

​​​​​​​“InnovAge is at the centre of multiple megatrends in US healthcare and stands alone in delivering a “win-win” to all key stakeholders.”

Pavithra Mahesh, Principal in the Apax Healthcare team

The views expressed in this publication reflect the current views of Apax Partners LLP (together with its affiliates, “Apax”) as of the date hereof and Apax undertakes no responsibility to advise you of any changes in the views expressed herein.

This publication is not intended to be, and must not be taken as, the basis for any investment decision by any recipient. No offer or solicitation of an offer in respect of any Apax fund is being made by Apax by communication of this publication and no reliance should be placed upon this publication by any person, nor should it act as an inducement to enter into any investment activity.

This publication discusses broad market, industry or sector trends, or other economic, market or political conditions, and may refer to securities of companies in which certain Apax funds may be invested, or in respect of which Apax may seek to or have provided services (or receive services from). No representation or warranty, either express or implied, is provided in relation to the accuracy, adequacy or completeness of the information contained herein. None of the information herein has been independently verified and neither Apax nor any other person accepts responsibility for the publication.

Past performance referred to herein is not indicative of future results and there is no assurance that any Apax fund will achieve its objectives or avoid significant losses. This publication may contain forward looking statements, including in relation to the financial condition, results of operations and businesses of companies referred to herein; any such statements are subject to various assumptions, risks and uncertainties, many of which are difficult to predict.

Recipient should not treat the contents of this publication as research or advice relating to legal, taxation, ERISA, financial, investment or accounting matters, or as a recommendation by Apax and are strongly advised to consult their own professional advisers concerning their own circumstances, or in relation to any investment concepts mentioned in this publication (which may be unsuitable for the recipient depending on their specific investment objectives and financial position).